These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1086087)

  • 1. A clinical study on the ototoxic effects of tobramycin.
    Lehmann W; Häusler R; Waldvogel FA
    Arch Otorhinolaryngol; 1976 Jul; 212(3):203-11. PubMed ID: 1086087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vestibulo-toxicity of tobramycin.
    Baarsma EA; Rijntjes E
    J Laryngol Otol; 1979 Jul; 93(7):725-7. PubMed ID: 313972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible tobramycin-induced bilateral high-frequency vestibular toxicity.
    Walsh RM; Bath AP; Bance ML
    ORL J Otorhinolaryngol Relat Spec; 2000; 62(3):156-9. PubMed ID: 10810261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery from vestibular ototoxicity.
    Black FO; Gianna-Poulin C; Pesznecker SC
    Otol Neurotol; 2001 Sep; 22(5):662-71. PubMed ID: 11568676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ototoxicity of tobramycin: a clinical overview.
    Neu HC; Bendush CL
    J Infect Dis; 1976 Aug; 134 Suppl():S206-18. PubMed ID: 1085788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ototoxicity of tobramycin in humans - influence of renal impairment.
    Brogard JM; Conraux C; Collard M; Lavillaureix J
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):408-16. PubMed ID: 6982875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglycoside ototoxicity.
    Matz GJ
    Am J Otolaryngol; 1986; 7(2):117-9. PubMed ID: 3485932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of the ototoxicity of aminoglycosides. Comparison of tobramycin and gentamycin. Preliminary report].
    Fee WE
    Nouv Presse Med; 1978 Nov; 7(42):3854-5. PubMed ID: 309592
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of nephrotoxic and ototoxic effects of tobramycin in worldwide study.
    Bendush CL; Senior SL; Wooller HO
    Med J Aust; 1977 Oct; 2(3 Pt 2 Suppl):22-6. PubMed ID: 304521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vestibulotoxicity as a consequence of systemically administered tobramycin in cystic fibrosis patients.
    Scheenstra RJ; Rijntjes E; Tavy DL; Kingma H; Heijerman HG
    Acta Otolaryngol; 2009 Jan; 129(1):4-7. PubMed ID: 18607923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced sudden hearing loss and vestibular disturbances.
    Federspil P
    Adv Otorhinolaryngol; 1981; 27():144-58. PubMed ID: 7034495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vestibular toxicity due to inhaled tobramycin in a patient with renal insufficiency.
    Edson RS; Brey RH; McDonald TJ; Terrell CL; McCarthy JT; Thibert JM
    Mayo Clin Proc; 2004 Sep; 79(9):1185-91. PubMed ID: 15357042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal and vestibular toxicity due to inhaled tobramycin in a lung transplant recipient.
    Ahya VN; Doyle AM; Mendez JD; Lipson DA; Christie JD; Blumberg EA; Pochettino A; Nelson L; Bloom RD; Kotloff RM
    J Heart Lung Transplant; 2005 Jul; 24(7):932-5. PubMed ID: 15982625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobramycin in the treatment of severe and complicated urinary tract infections.
    Bailey RR; Peddie B
    N Z Med J; 1976 Jul; 84(567):1-3. PubMed ID: 823477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.
    Lenoir G; Antypkin YG; Miano A; Moretti P; Zanda M; Varoli G; Monici Preti PA; Aryayev NL
    Paediatr Drugs; 2007; 9 Suppl 1():11-20. PubMed ID: 17536871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory study of tobramycin in the treatment of infections due to gram-negative organisms.
    Marrie TJ; Gurwith MJ; Ronald AR; Stiver HG; Lank B; Fox L
    Can Med Assoc J; 1977 Jul; 117(2):138-43. PubMed ID: 406032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dosage tobramycin treatment of children with cystic fibrosis. Bacteriological effect and clinical ototoxicity.
    Thomsen J; Friis B
    Int J Pediatr Otorhinolaryngol; 1979 Jul; 1(1):33-40. PubMed ID: 553884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy.
    Hoffmann IM; Rubin BK; Iskandar SS; Schechter MS; Nagaraj SK; Bitzan MM
    Pediatr Pulmonol; 2002 Nov; 34(5):375-7. PubMed ID: 12357482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute renal failure associated with use of inhaled tobramycin for treatment of chronic airway colonization with Pseudomonas aeruginosa.
    Izquierdo MJ; Gomez-Alamillo C; Ortiz F; Calabia ER; Ruiz JC; de Francisco AL; Arias M
    Clin Nephrol; 2006 Dec; 66(6):464-7. PubMed ID: 17176920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobramycin ototoxicity. Repeated courses of high dosage treatment in children with cystic fibrosis.
    Thomsen J; Friis B; Jensen K; Bak-Pedersen K; Larsen PK
    J Antimicrob Chemother; 1979 May; 5(3):257-60. PubMed ID: 479061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.